Nuvation Bio: Look Forward to Further Advancing Taletrectinib and Plan to Share Results From Global, Pivotal Trust-II Study by End of 2024
Nuvation Bio:期待進一步推進Taletrectinib的發展,並計劃在2024年底之前分享全球關鍵性Trust-II研究的結果
Nuvation Bio: Look Forward to Further Advancing Taletrectinib and Plan to Share Results From Global, Pivotal Trust-II Study by End of 2024
Nuvation Bio:期待進一步推進Taletrectinib的發展,並計劃在2024年底之前分享全球關鍵性Trust-II研究的結果
譯文內容由第三人軟體翻譯。